Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey

M Mac Aogáin1, C Kulah, M Rijnsburger

  • 1BIOMERIT Research Centre, Department of Microbiology, University College Cork, Cork, Ireland.

Insights

Carbapenem resistance in Pseudomonas aeruginosa is a growing threat. Mutational disruption of the oprD gene was the primary mechanism driving imipenem resistance in Turkish hospital isolates.

Area of Science:

  • Clinical microbiology and infectious diseases.
  • Molecular mechanisms of antibiotic resistance.

Background:

  • Carbapenem resistance in Pseudomonas aeruginosa poses a significant threat to treating infections caused by this opportunistic pathogen.
  • An increasing trend of carbapenem-resistant P. aeruginosa was observed at Zonguldak Karaelmas University Hospital, Turkey, between 2003 and 2006.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the emergence of imipenem resistance in P. aeruginosa isolates.
  • To characterize the genetic diversity and clonal relationships among resistant isolates.

Main Methods:

  • Amplified fragment length polymorphism (AFLP) typing was employed to assess the genetic diversity and identify clonal outbreaks.
  • Molecular characterization of carbapenem resistance mechanisms was performed on representative isolates from identified clonal groups.

Main Results:

  • AFLP analysis revealed genetic diversity among imipenem-resistant P. aeruginosa, identifying two distinct clonally related outbreak groups.
  • Mutational disruption of the oprD gene was identified as the predominant mechanism of carbapenem resistance, found in 23 out of 27 isolates studied.
  • Other resistance mechanisms were present but less frequent than oprD disruption.

Conclusions:

  • Mutational disruption of oprD is a major contributor to carbapenem resistance in P. aeruginosa isolates from this Turkish hospital.
  • The findings highlight the importance of monitoring resistance mechanisms to guide antimicrobial stewardship and treatment strategies against P. aeruginosa infections.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...